Hyaluronan and type III procollagen peptide concentrations in bronchoalveolar lavage fluid in idiopathic pulmonary fibrosis.
Open Access
- 1 February 1989
- Vol. 44 (2) , 126-131
- https://doi.org/10.1136/thx.44.2.126
Abstract
The connective tissue components hyaluronan (hyaluronic acid) and type III procollagen peptide were measured in bronchoalveolar lavage fluid in 22 patients with idiopathic pulmonary fibrosis and 21 healthy control subjects. The patients with idiopathic pulmonary fibrosis had higher concentrations of hyaluronan (median 46 micrograms/l) and type III procollagen peptide (median 0.45 micrograms/l) than the healthy controls (9 and less than 0.02 micrograms/l; p less than 0.001). The patients had normal serum concentrations of hyaluronan and of the procollagen peptide, and albumin concentrations in lavage fluid similar to those of the control subjects. Neutrophil and lymphocyte counts in lavage fluid were increased on average 10 and two fold respectively in the patients with idiopathic pulmonary fibrosis and both correlated with the amount of hyaluronan recovered (p less than 0.05). An inverse correlation was seen between the transfer factor for carbon monoxide and hyaluronan concentrations in lavage fluid in the patients (p less than 0.05). Deterioration in lung function and radiographic progression were seen over six months in 12 of the patients. These patients had higher lavage fluid concentrations of hyaluronan and type III procollagen peptide than the patients whose disease was stable (p less than 0.01). Increased synthesis of hyaluronan and type III procollagen peptide in lung parenchyma may reflect activation or proliferation (or both) of pulmonary fibroblasts in idiopathic pulmonary fibrosis and seems to be linked to the severity and activity of the lung disease.This publication has 33 references indexed in Scilit:
- Exaggerated Spontaneous Release of Platelet-Derived Growth Factor by Alveolar Macrophages from Patients with Idiopathic Pulmonary FibrosisNew England Journal of Medicine, 1987
- The Mast Cell and Signs of Pulmonary Fibroblast Activation in SarcoidosisInternational Archives of Allergy and Immunology, 1987
- Serum type III procollagen peptide concentration in cryptogenic fibrosing alveolitis and its clinical relevance.Thorax, 1984
- Interstitial Lung Diseases of Unknown CauseNew England Journal of Medicine, 1984
- Increased Bronchoalveolar IgG-Secreting Cells in Interstitial Lung DiseasesNew England Journal of Medicine, 1980
- Radioimmunoassay for type III procollagen peptide and its application to human liver diseaseEuropean Journal of Clinical Investigation, 1979
- Collagenase in the Lower Respiratory Tract of Patients with Idiopathic Pulmonary FibrosisNew England Journal of Medicine, 1979
- Circulating Immune Complexes in the Idiopathic Interstitial PneumoniasNew England Journal of Medicine, 1978
- Biochemical characteristics and biological significance of the genetically-distinct collagensMolecular and Cellular Biochemistry, 1976
- Spirometric Studies in Normal Subjects IActa Medica Scandinavica, 1963